Certara Investor Day Presentation Deck

Drug R&D grows in complexity and cost Cost Small Molecules Peptides Cell & Gene Therapy Antibodies Complexity Cost of development grows with complexity of compound Clinical phase times are increasing Biologics comprise 43% of the R&D pipeline Complex generics also pose development challenges 12 CERTARA

View entire presentation